Listen to this story:

The quick read: Penticton has been chosen as one of the sites for an international clinical trial of a new opioid treatment, the Medical Arts Health Research Group announced November 6. Participant selection is expected to begin this month. The trial tests an investigational medication alongside existing buprenorphine treatment for adults in early recovery from opioid use disorder.

Penticton is getting a shot at something the Okanagan desperately needs: a better way out of opioid addiction.

The Medical Arts Health Research Group announced on November 6 that Penticton will be one of the sites for an international clinical trial of a new opioid treatment method, with participant selection expected to begin this month.

What the trial tests

The trial evaluates an investigational medication taken alongside existing buprenorphine treatment for adults in early recovery from opioid use disorder.

Buprenorphine is already one of the most effective medications for treating opioid addiction.

The question the trial asks is whether adding a new medication on top of it helps more people stay in recovery, for longer.

The same research group is running the trial in Kamloops, where recruitment opened in October, and the study operates under Health Canada and research ethics oversight.

Why this matters here

The overdose crisis has hit the Okanagan hard, and Penticton has felt it as much as any community in the valley.

Canada's overdose crisis claims more than 21 lives a day across the country, according to the Centre for Addiction and Mental Health, and the toll in B.C. has been among the worst in the nation.

For years, the public response has leaned heavily on managing the crisis: safe supply, supervised sites, and harm reduction that keeps people alive but too often leaves them exactly where they were.

Keeping people alive matters.

But it is not the same as helping them recover, and a community that only manages addiction will be managing it forever.

Recovery is the goal

That is what makes a treatment trial different, and worth cheering for.

It is aimed at the thing that actually ends addiction: getting people stable, getting them off opioids, and getting them back to work, family, and a normal life.

If the medication works, Penticton will have been part of proving it, and the Okanagan will have one more tool to offer people who are ready to get clean.

That is the kind of investment in this crisis that deserves to succeed.

Sources: Summerland Review, November 7, 2026; CFJC Today, October 25, 2026; Centre for Addiction and Mental Health.